437
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013

, , &
Pages 925-937 | Published online: 13 May 2015

Figures & data

Table 1 Prevalence rates (per 1,000 persons) and incidence rates (per 1,000 person-years) by GOLD category

Figure 1 Age-stratified prevalence rates by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) category.

Abbreviations: GOLD A, low symptoms, low risk; GOLD B, high symptoms, low risk; GOLD C, low symptoms, high risk; GOLD D, high symptoms, high risk.
Figure 1 Age-stratified prevalence rates by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) category.

Figure 2 Age-stratified incidence rates by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) category.

Abbreviations: GOLD A, low symptoms, low risk; GOLD B, high symptoms, low risk; GOLD C, low symptoms, high risk; GOLD D, high symptoms, high risk.
Figure 2 Age-stratified incidence rates by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) category.

Figure 3 Study patient identification.

Figure 3 Study patient identification.

Table 2 Characteristics of the prevalent and incident cohorts

Table 3 COPD therapy for stable COPD in the prevalent and incident cohorts

Table 4 GOLD classification parameters for the prevalent and incident cohorts

Table 5 Characteristics of the prevalent cohort: GOLD A/B and GOLD C/D

Table 6 COPD therapy for stable COPD in the prevalent cohort: GOLD A/B and GOLD C/D

Table 7 Characteristics of the incident cohort: GOLD A/B and GOLD C/D

Table 8 Chronic obstructive pulmonary disease maintenance therapy in the incident cohort: GOLD A/B and GOLD C/D